Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Swiss Caps AG | Kirchberg, Switzerland | Makes it | Problems found, fixed voluntarilyJun 29, 2023 · 6 inspections |
Recalls
- Aug 24, 2018 · Class II · Akorn, Inc.
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
Lots: Lots: 1165280100, 1165280101, EXP 3/2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ethosuximide: every company that makes it
- Form
- capsule
- Strength
- 250 mg
- Approval
- ANDA ANDA040686
- On the market since
- Sep 1, 2008
- Package NDCs
61748-025-01- Official label
- DailyMed (National Library of Medicine), updated Mar 8, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?